Metraipolis › archive › dc_57efe712fd1a

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma — Europe PMC PMID:42215622

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42215622
DOI
10.1038/s41409-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-11-01T04:10:01.626Z
SHA-256 of the archived text
53253fd15d5c20ddaf594b5ff3a7f38e4bc87dbb4f1326ace2b6e77980c27625
Stable URL of this page
https://metraipolis.com/documento/dc_57efe712fd1a

How to cite

A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma — Europe PMC PMID:42215622 — Europe PMC (en), https://europepmc.org/article/MED/42215622 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_57efe712fd1a (Metraipolis archive dc_57efe712fd1a, sha256 53253fd15d5c20ddaf594b5ff3a7f38e4bc87dbb4f1326ace2b6e77980c27625)
BibTeX
@misc{dc57efe712fd1a,
  title = {A pilot study combining primary busulfan-based haploidentical stem cell transplantation with GD2 antibody to treat high-risk neuroblastoma — Europe PMC PMID:42215622},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42215622},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_57efe712fd1a; sha256 53253fd15d5c20ddaf594b5ff3a7f38e4bc87dbb4f1326ace2b6e77980c27625},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42215622. Agents can read the archived copy with the MCP tool read_document.